Jiangsu, China

Chenchen Wu

This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Hansoh Pharmaceutical Co., Ltd.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chenchen Wu. Retrieved from https://idiyas.com/inventor/chenchen-wu-2f3hfcht

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chenchen Wu: Pharmaceutical Invention and Patent

Introduction

Chenchen Wu is a woman inventor associated with Jiangsu, China, and Jiangsu Hansoh Pharmaceutical Co., Ltd. Her listed patent concerns a class of triazolopyridine derivatives and their potential pharmaceutical applications.

Latest Patents

The provided information lists one patent for Chenchen Wu: “[1,2,4] Triazol[4,3-A] Pyridine Derivative, Preparation Method Therefor or Medical Application Thereof.” The invention describes derivatives of the specified chemical class, methods for preparing them, and pharmaceutical compositions containing them. The compositions are proposed for therapeutic use, particularly as c-Met inhibitors and immunosuppressants. The patent description states that the substituents in the general formula are defined in the specification. Chenchen Wu is credited with 1 patent in the information provided.

Career Highlights

Wu’s listed work is connected to pharmaceutical research and the development of potential therapeutic compounds. Her association with Jiangsu Hansoh Pharmaceutical Co., Ltd. places this invention within a company focused on pharmaceutical development.

Collaborations

The provided information names Zhiming Zhao and Qingqing Qi as Wu’s coworkers. It does not specify their roles or the nature of their contributions to the patent.

Conclusion

Chenchen Wu’s listed patent describes triazolopyridine derivatives, their preparation, and their potential use in therapeutic compositions, including as c-Met inhibitors and immunosuppressants.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…